"Venous Thromboembolism" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Obstruction of a vein or VEINS (embolism) by a blood clot (THROMBUS) in the blood stream.
| Descriptor ID |
D054556
|
| MeSH Number(s) |
C14.907.355.590.700
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Venous Thromboembolism".
Below are MeSH descriptors whose meaning is more specific than "Venous Thromboembolism".
This graph shows the total number of publications written about "Venous Thromboembolism" by people in this website by year, and whether "Venous Thromboembolism" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2008 | 4 | 0 | 4 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 4 | 0 | 4 |
| 2013 | 4 | 2 | 6 |
| 2014 | 3 | 1 | 4 |
| 2015 | 7 | 0 | 7 |
| 2016 | 14 | 4 | 18 |
| 2017 | 107 | 15 | 122 |
| 2018 | 145 | 21 | 166 |
| 2019 | 59 | 8 | 67 |
| 2020 | 94 | 19 | 113 |
| 2021 | 75 | 21 | 96 |
| 2022 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Venous Thromboembolism" by people in Profiles.
-
Thromboprophylaxis in Patients with COVID-19: Systematic Review of National and International Clinical Guidance Reports. Curr Vasc Pharmacol. 2022; 20(1):96-110.
-
Low molecular weight heparin is useful in adult COVID-19 inpatients. Experience during the first Spanish wave: observational study. Sao Paulo Med J. 2022 Jan-Feb; 140(1):123-133.
-
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients. Blood Adv. 2021 10 26; 5(20):3951-3959.
-
Janus Kinase inhibitors for the treatment of hospitalized patients with COVID-19. Curr Opin Crit Care. 2021 10 01; 27(5):493-496.
-
A Rapid Guidance Process for the Development of an Anticoagulation Protocol in the COVID-19 Pandemic. Qual Manag Health Care. 2021 Oct-Dec 01; 30(4):276-279.
-
Lupus Anticoagulant Single Positivity During the Acute Phase of COVID-19 Is Not Associated With Venous Thromboembolism or In-Hospital Mortality. Arthritis Rheumatol. 2021 11; 73(11):1976-1985.
-
[Pulmonary embolism and SARS-CoV-2: analysis of patients hospitalized for pulmonary embolism and COVID-19 in a Northern Italian center]. G Ital Cardiol (Rome). 2021 Sep; 22(9):704-711.
-
Bacterial surinfection and venous thromboembolism in critically ill ICU patients with COVID-19: What is the relationship? Thromb Res. 2021 10; 206:139-141.
-
Venous thromboembolism is not a risk factor for the development of bloodstream infections in critically ill COVID-19 patients. Thromb Res. 2021 10; 206:128-130.
-
Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program. Am J Clin Dermatol. 2021 Sep; 22(5):693-707.